Enter the password to continue.
A quick reference for our birth team & hospital staff
We prefer the oral route and want to avoid the injection unless our baby is in a higher-risk category. We understand the trade-off and we are committing to the full multi-dose schedule, which is what makes oral protection work.
Most evidence-based schedule (German/Swiss 2 mg regimen — both this and the Danish weekly option below get late-VKDB under 1 in 100,000):
Product:
| Dose | When | Date given | Done |
|---|---|---|---|
| Dose 1 — 2 mg | At birth, with first feeding | ||
| Dose 2 — 2 mg | Day 4–6 | ||
| Dose 3 — 2 mg | Week 4–6 |
Danish weekly alternative: 2 mg at birth, then 1 mg every week for 3 months (good for exclusively breastfed babies). US reality check: there is no FDA-approved infant oral vitamin K in the US — available options are unregulated supplements with variable dosing, so confirm the exact product and schedule with our provider.
The ointment exists mainly to prevent gonococcal eye infection (ophthalmia neonatorum). It does not reliably prevent chlamydial or other bacterial eye infections, and the at-birth dose can briefly blur baby's vision during our first bonding hour. With a low-risk screening picture, declining is reasonable — the AAP itself stopped recommending universal use in 2018.
Mom's gonorrhea & chlamydia screening in pregnancy: Date/notes:
If screening is negative, we are in a low-risk relationship, and we have fast access to care, the risk of declining is very low.
Some states mandate eye prophylaxis and may require a signed refusal/waiver. Ask our provider what's needed in our hospital ahead of time.
So we're making these calls with eyes open.